Sign in / Join Now
ETFs & Funds
looks to be down due to $
deal. Time to find a new bottom.
Add a reply...
Latest StockTalks »
people get LXRX breaking news and analysis by email alert.
Get email alerts on LXRX »
Lexicon Pharmaceuticals, Inc.
Get latest price
From other sites
Lexicon Begins Phase 1 Clinical Trial Of Locally-acting SGLT1 Inhibitor, LX2761, For Potential Treatment Of Diabetes
at TheStreet (Jan 9, 2017)
Lexicon To Present At The 35th Annual J.P. Morgan Healthcare Conference
at TheStreet (Jan 5, 2017)
First Week of LXRX February 2017 Options Trading
at TheStreet (Dec 22, 2016)
Lexicon Reports Positive Top-line Results In Second Pivotal Phase 3 Study For Sotagliflozin In Patients With Type 1 Diabetes
at TheStreet (Dec 21, 2016)
Notable Friday Option Activity: LXRX, WTW, XBIT
at TheStreet (Dec 16, 2016)